My watch list  

4 Current news


You can refine your search further. Select from the filter options on the left to narrow down your results.

QIAGEN to submit conditional voluntary takeover offer for shares of Exiqon A/S


QIAGEN N.V. announced that it has decided to submit a conditional voluntary takeover offer to the shareholders of Exiqon A/S to purchase all shares in Exiqon. The acquisition is expected to expand...


Michael Kallelis to manage Exiqon's new us facility

Exiqon's US operations will start Q1 2006


Exiqon A/S announced the appointment of Michael Kallelis as President and General Manager of Exiqon's new US operations. Mr. Kallelis will have the overall responsibility for launching and operating...


Exiqon A/S wins prestigious Ernst & Young Entrepreneur of the Year Award


Exiqon A/S announced that it has won the Ernst & Young Entrepreneur Of The Year award in the category Biotech 2005. The prestigious award is created to identify and acknowledge the most successful...


U.S. Genomics Licenses Locked Nucleic Acid (LNA(TM)) Chemistries from Exiqon

LNA(TM) chemistries included in Trilogy(TM) platform reagent kits for microRNA analysis


Woburn and Copenhagen. U.S. Genomics and Exiqon have entered into a worldwide license agreement to incorporate Exiqon's Locked Nucleic Acid (LNA(TM)) chemistries into reagent kits for the U...


Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE